The significance of the crosstalk between ubiquitination or deubiquitination and ncRNAs in non-small cell lung cancer

被引:6
|
作者
Sun, Yiyang [1 ]
He, Ping [1 ]
Li, Li [1 ]
Ding, Xue [2 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Gerontol & Geriatr, Shenyang, Peoples R China
[2] Dalian Friendship Hosp, Gen Med Dept, Dalian, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2023年 / 12卷
关键词
miRNA; lncRNA; circRNA; ubiquitination; deubiquitination; NSCLC; CISPLATIN RESISTANCE; NONCODING RNAS; LNCRNA H19; TUMOR PROLIFERATION; DOWN-REGULATION; A549/DDP CELLS; UP-REGULATION; IN-VITRO; PROMOTES; METASTASIS;
D O I
10.3389/fonc.2022.969032
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer (LC) remains the leading cause of cancer-related deaths worldwide, with extremely high morbidity and mortality rates. Non-small cell lung cancer (NSCLC) is the most critical type of LC. It seriously threatens the life and health of patients because of its early metastasis, late clinical symptoms, limited early screening methods, and poor treatment outcomes. Non-coding RNAs (ncRNAs), including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), participate in cell proliferation, metastasis, and chemoresistance. Several previous studies have proven that ncRNAs are vital regulators of tumorigenesis. Ubiquitination plays the most crucial role in protein post-translational modification (PTM). Deubiquitination and ubiquitination form a homeostasis. In summary, ubiquitination and deubiquitination play essential roles in mediating the degradation or overexpression of a range of crucial proteins in various cancers. A growing number of researchers have found that interactions between ncRNAs and ubiquitination (or deubiquitination) play a crucial role in NSCLC. This review presents several typical examples of the important effects of ncRNAs and ubiquitination (or deubiquitination) in NSCLC, aiming to provide more creative ideas for exploring the diagnosis and treatment of NSCLC.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Clinical significance of surgical resection for recurrent non-small cell lung cancer
    Hishida, T
    Nagai, K
    Yoshida, J
    Ishii, G
    Nishimura, M
    Nishiwaki, Y
    Saijo, N
    LUNG CANCER, 2005, 49 : S349 - S350
  • [32] Significance of Serum MicroRNAs in the Auxiliary Diagnosis of Non-Small Cell Lung Cancer
    Shi, Guang-Li
    Chen, Yan
    Sun, Yong
    Yin, Yan-Jun
    Song, Chang-Xing
    CLINICAL LABORATORY, 2017, 63 (01) : 133 - 140
  • [33] The clinical significance of CXCL5 in non-small cell lung cancer
    Wu, Kongju
    Yu, Shengnan
    Liu, Qian
    Bai, Xianguang
    Zheng, Xinhua
    Wu, Kongming
    ONCOTARGETS AND THERAPY, 2017, 10 : 5561 - 5573
  • [34] Prognostic significance of CD276 in non-small cell lung cancer
    Zhang, Changgong
    Hao, Xuezhi
    OPEN MEDICINE, 2019, 14 (01): : 805 - 812
  • [35] Prognostic Significance of Nestin Expression in Resected Non-small Cell Lung Cancer
    Ryuge, Shinichiro
    Sato, Yuichi
    Wang, Guo Qin
    Matsumoto, Toshihide
    Jiang, Shi Xu
    Katono, Ken
    Inoue, Hayato
    Satoh, Yukitoshi
    Masuda, Noriyuki
    CHEST, 2011, 139 (04) : 862 - 869
  • [36] Prognostic significance of Notch ligands in patients with non-small cell lung cancer
    Pancewicz-Wojtkiewicz, Joanna
    Eljaszewicz, Andrzej
    Kowalczuk, Oksana
    Niklinska, Wieslawa
    Charkiewicz, Radoslaw
    Kozlowski, Miroslaw
    Miasko, Agnieszka
    Moniuszko, Marcin
    ONCOLOGY LETTERS, 2017, 13 (01) : 506 - 510
  • [37] Prognostic significance of serum sMICA levels in non-small cell lung cancer
    Wang, L. -P.
    Niu, H.
    Xia, Y. -F.
    Han, Y. -L.
    Niu, P.
    Wang, H. -Y.
    Zhou, Q. -L.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2015, 19 (12) : 2226 - 2230
  • [38] Prognostic significance of RelB overexpression in non-small cell lung cancer patients
    Qin, Hualong
    Zhou, Jun
    Zhou, Peng
    Xu, Jingjing
    Tang, Zaixiang
    Ma, Haitao
    Guo, Feng
    THORACIC CANCER, 2016, 7 (04) : 415 - 421
  • [39] Prognostic significance of TIMP-1 in non-small cell lung cancer
    Kulda, V.
    Pesta, M.
    Topolcan, O.
    Pesek, M.
    Vrzalova, J.
    Treska, V.
    Safranek, J.
    Liska, V.
    Holubec, L.
    Cerny, R.
    FEBS JOURNAL, 2011, 278 : 216 - 216
  • [40] Maspin expression and its clinical significance in non-small cell lung cancer
    Nakagawa, Masatsugu
    Katakura, Hiromichi
    Adachi, Masashi
    Takenaka, Kazumasa
    Yanagihara, Kazuhiro
    Otake, Yosuke
    Wada, Hiromi
    Tanaka, Fumihiro
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (11) : 1517 - 1523